OXRA L TABLETS

Composition: DAPAGLIFLOZIN 10MG+LINAGLIPTIN 5MG

Drug Class: Combination medicine

Marketed by: Sun Pharmaceutical Industries Limited

MRP: ₹198.75

A fixed-dose combination of Dapagliflozin and Linagliptin.

Uses / Indications

Controls blood sugar

Side Effects

May include effects of its ingredients such as stomach upset, dizziness, headache or drowsiness.

Precautions / Warnings

Use exactly as prescribed. Tell your doctor about your other medicines and health conditions. Complete the course where applicable.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.